Clinical Trial

Excision BioTherapeutics Announces Publication Highlighting EBT-107 for the Treatment of Chronic Hepatitis B in bioRxiv

Treatment with EBT-107 led to a rapid reduction in clinical biomarkers and suppression of random HBV DNA integration with minimal…

7 months ago

NervGen Pharma Reports Q1 2025 Financial Results and Provides Operational Updates

Completed last subject, last visit in the chronic cohort, data readout targeted for early June 2025Vancouver, British Columbia--(Newsfile Corp. -…

7 months ago

Conference Forum Announces the Partnerships with Sites Summit to Improve Patient Enrollment

The Conference Forum announces the Partnerships with Sites Summit to address the unmet need of patient enrollment at clinical sites…

8 months ago

Sanford Health and Cedar Partner to Bring Cutting-Edge Financial Solutions to Rural Care

The nation's largest rural Epic health system selects Cedar to enhance the patient financial experience in America's heartland NEW YORK, May…

8 months ago

REACH Trial Evaluating First-Line Treatment of Refractory Chronic Cough Completes Enrollment

Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company pioneering treatments for respiratory illnesses…

8 months ago

REACH Trial Evaluating First-Line Treatment of Refractory Chronic Cough Completes Enrollment

Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company pioneering treatments for respiratory illnesses…

8 months ago

Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

– Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14,…

8 months ago

Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settingsVANCOUVER, British…

8 months ago

Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results

- VCN-01 Achieves Primary Efficacy and Safety Endpoints for Pancreatic Ductal Adenocarcinoma in VIRAGE Phase 2b Clinical Trial - -…

8 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Clear Regulatory Path to Clinical Trials for Intranasal PTSD Therapy Targeting Multi-Billion-Dollar MarketSARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) --…

8 months ago